Skip to main content
  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

  • Home
  • About this Journal
    • Editorial Board
    • Meet the Editors
    • Editorial Manifesto
    • Impact Factor
    • Journal History
    • General Statistics
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • Circulation Research Profiles
    • Trainees & Young Investigators
    • Research Around the World
    • News & Views
    • The NHLBI Page
    • Viewpoints
    • Compendia
    • Reviews
    • Recent Review Series
    • Profiles in Cardiovascular Science
    • Leaders in Cardiovascular Science
    • Commentaries on Cutting Edge Science
    • AHA/BCVS Scientific Statements
    • Abstract Supplements
    • Circulation Research Classics
    • In This Issue Archive
    • Anthology of Images
  • Resources
    • Online Submission/Peer Review
    • Why Submit to Circulation Research
    • Instructions for Authors
    • → Article Types
    • → Manuscript Preparation
    • → Submission Tips
    • → Journal Policies
    • Circulation Research Awards
    • Image Gallery
    • Council on Basic Cardiovascular Sciences
    • Customer Service & Ordering Info
    • International Users
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
  • Impact Factor 13.965
  • Facebook
  • Twitter

  • My alerts
  • Sign In
  • Join

  • Advanced search

Header Publisher Menu

  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

Circulation Research

  • My alerts
  • Sign In
  • Join

  • Impact Factor 13.965
  • Facebook
  • Twitter
  • Home
  • About this Journal
    • Editorial Board
    • Meet the Editors
    • Editorial Manifesto
    • Impact Factor
    • Journal History
    • General Statistics
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • Circulation Research Profiles
    • Trainees & Young Investigators
    • Research Around the World
    • News & Views
    • The NHLBI Page
    • Viewpoints
    • Compendia
    • Reviews
    • Recent Review Series
    • Profiles in Cardiovascular Science
    • Leaders in Cardiovascular Science
    • Commentaries on Cutting Edge Science
    • AHA/BCVS Scientific Statements
    • Abstract Supplements
    • Circulation Research Classics
    • In This Issue Archive
    • Anthology of Images
  • Resources
    • Online Submission/Peer Review
    • Why Submit to Circulation Research
    • Instructions for Authors
    • → Article Types
    • → Manuscript Preparation
    • → Submission Tips
    • → Journal Policies
    • Circulation Research Awards
    • Image Gallery
    • Council on Basic Cardiovascular Sciences
    • Customer Service & Ordering Info
    • International Users
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
Editorial

Beware the Air!

Why Particulate Matter Matters

Daniel J. Conklin
Download PDF
https://doi.org/10.1161/CIRCRESAHA.111.241174
Circulation Research. 2011;108:644-647
Originally published March 17, 2011
Daniel J. Conklin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Info & Metrics

Jump to

  • Article
    • Sources of Funding
    • Disclosures
    • Footnotes
    • References
  • Figures & Tables
  • Info & Metrics
  • eLetters
Loading
  • Ly6C cells
  • perivascular adipose
  • PM2.5 POVPC
  • vascular inflammation

See related article, pages 716 – 726

The “Six Cities Study,” as it is affectionately known by epidemiologists, was published in 1993. This landmark study laid the groundwork for an association between ambient air particulate matter (ie, fine particulate matter [PM] or PM2.5 [particulate matter of 2.5 μm aerodynamic diameter or less]) and the risk of all cause mortality in the United States.1 Simply put, the message of the study was: “Air pollution kills.” Since then, a steady stream of studies has grown into a river of reports that collectively have swelled the banks of this initial association and have further specified that ischemic heart disease (cardiovascular disease [CVD]) is the single-most abundant cause of morbidity and mortality in this association.2,–,4 Analysis of more than 100 studies (>100 million people in 119 cities in the United States and Europe) show that for each 10 μg/m3 acute or chronic increase in PM2.5, there is a significant increase in relative risk of cardiovascular mortality (chronic relative risk, 1.06 to 1.76), indicating that PM, even at ambient levels, has negative health consequences.4 Moreover, chronic exposure to each 10 μg/m3 PM2.5 increase is associated with a 4 to 6% increase in CVD deaths, which translates to 800 000 deaths annually in the world (according to the World Health Organization), making PM exposure the 13th leading cause of CVD deaths4 and, thus, deserving of urgent scientific and social attention. Currently, researchers in the field of environmental cardiology5 are addressing at least 1 of 2 major unanswered questions regarding this association: (1) What constituent of inhaled PM2.5 is responsible for the association?; and (2) What is the mechanism by which inhaled PM2.5 can specifically affect cardiovascular disease risk?

In this issue of Circulation Research, Kampfrath et al address the latter “mechanistic question” and provide, for the first time, a biologically plausible mechanism that connects PM2.5 exposure with vascular inflammation and dysfunction.6 To do so, the group tracked oxidative changes induced in the lungs following chronic exposure to concentrated ambient PM2.5 (CAPs) to the terminal changes of vascular inflammation and dysfunction in the aortic wall and in several other systemic vascular beds as well, which ultimately increases risk for CVD (eg, promoting atherosclerosis, thrombosis). Although it is nearly cliché to read that inhaled particles (PM2.5, nanoparticles) induce “oxidative stress and/or lipid peroxidation” in the lungs and systemically and that this leads to cardiovascular inflammation and dysfunction, one finds in the present study of Kampfrath et al that “oxidative stress” has a molecular identity in the derivatives of oxidized phospholipid 1-palmitoyl-2-arachidonyl-sn-glycero-3-phosphorylcholine (oxPAPC), including 1-palmitoyl-2-(5′-oxo-valeroyl)-sn-glycero-3-phosphocholine (POVPC), a well-known constituent of oxidized low-density lipoprotein, which can directly activate endothelial cells and stimulate the release/production of interleukin-8 (KC in mice) via Toll-like receptor (TLR)4 and an associated protein.7,8 Nonetheless, POVPC (or a related lipid peroxidation product) generated in the lungs after PM2.5 exposure appears to touch off a positive-feedback response in the lungs that also involves TLR4 and NADPH oxidase, leading to enhanced superoxide production and mobilization of mononuclear cells (eg, F4/80+, LyG6+high, c-fms+ cells) from bone marrow into the circulation, lungs, and vascular wall, specifically into the perivascular adipose (Figure). The emphasis on this latter step whereby mononuclear (inflammatory) cells home to perivascular adipose is timely and, more importantly, provides a plausible link between a disparate number of stimuli (eg, CAPs, high-fat diet–induced obesity,9,10 metabolic syndrome and diabetes,11 angiotensin II infusion, and hypertension12) and vascular inflammation and vascular/endothelial dysfunction. Once a sufficient number of F4/80 (c-fms+ or LyG6+high) cells has homed to the vascular wall, there is a significant increase in NADPH oxidase– and perivascular-derived superoxide. Both the TLR4 and NADPH oxidase dependences of vascular inflammation were elegantly shown by Kampfrath et al, through chronic CAPs exposure of mice deficient in either the TLR4 or the NADPH oxidase subunit Nox2 (gp91phox−/−) proteins.6 It is worth noting, however, that various mechanistic steps were shown in different mouse strains.

Figure.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure.

Mechanism of PM2.5 induction of vascular inflammation. Ambient PM2.5 is selectively concentrated by the VACES and then inhaled. PM2.5 interacts with pulmonary cells and initiates lipid oxidation, generating oxPAPC and POVPC, which activate TLR4-dependent pathways including increased NADPH oxidase expression. Released cytokines and chemokines stimulate bone marrow–derived mononuclear cells (BMDCs especially Ly6C+high) to home to the perivascular adipose and increase vascular formation of NADPH oxidase–dependent superoxide, which contributes to endothelial activation and dysfunction. (Illustration credit: Cosmocyte/Ikumi Kayama.)

The significance of these findings extends beyond the important mechanistic insights. Exposure of normal, healthy mice to real world particle (CAPs) pollution demonstrates that this level of pollution is alone sufficient to induce systemic vascular inflammation/dysfunction without any additional stressor required (eg, angiotensin II infusion, high fat diet, “second hit”). Moreover, the level of PM2.5 exposure is relevant to human exposures. Mice were exposed for 6 h/d, 5 d/wk for 20 weeks using a versatile aerosol concentration enrichment system (VACES) to an average level of 92 μg/m3 PM2.5. This CAPs level is ≈9 times higher than the average ambient PM2.5 of 10 μg/m3 in Columbus, OH, whereas, the annual mean US National Ambient Air Quality Standards (NAAQS) for PM2.5 is 15 μg/m3. Because mice were exposed for only 6 h/d and not on weekends, overall exposure level is approximately equivalent to the annual US NAAQS and the World Health Organization annual mean PM2.5 of 10 μg/m3. The significance of this exposure condition is best appreciated when assessing daily and annual levels of PM2.5 in major cities around the globe, as in China,13,14 India,15 and eastern Europe.16 For example, daily average PM2.5 in Shanghai, China, is 56.4 μg/m3,13 with levels regularly exceeding 100 μg/m3 because of a confluence of traffic, coal burning, industry, and meteorologic conditions.14 Similarly, during a winter inversion event in the Wasatch Valley of Utah, PM2.5 significantly increased with peak levels reaching 150 μg/m3.17 Importantly, exposure to this elevated PM2.5 level significantly decreases the number of circulating endothelial progenitor cells17 in healthy young adults, indicating that acute PM2.5 exposure (as well as chronic) also initiates systemic vascular injury.18 Whether this striking acute event involves similar mechanisms as presented by Kampfrath et al6 (ie, lung oxidation, POVPC generation, TLR4 activation, and upregulation of NADPH oxidase) remains to be seen but provides, at minimum, evidence that circulating endothelial progenitor cells could be a useful “PM2.5 bellwether” for predicting vascular insult/dysfunction during PM2.5 exposures.

Like all good research, this study raises more questions than it answers. For example, in what cells does pulmonary oxPAPC or POVPC stimulate TLR4 (eg, lung macrophage, lung microvascular endothelial cells)? Similarly, it is not only possible but likely that additional products of oxPAPC, namely free, unsaturated aldehydes, such as 4-hydroxy-nonenal (HNE), are involved in inflammatory signaling. HNE is generated in equal molar amounts with POVPC following β-scission of lipid peroxides. Whereas POVPC is membrane-bound and saturated, HNE is far more reactive (α,β-unsaturated), has greater diffusive mobility, and induces a variety of proinflammatory, proliferative, and cytotoxic effects in vascular cells.19,–,22 In any case, the role of specific oxidized products generated in the lungs following PM2.5 exposure in activation of TLR4-dependent pathways remains an important question. Systemically, the signals that induce homing of mononuclear cells into the perivascular adipose and induce conversion of perivascular fat from benign regulator of vascular tone23 to an inflammatory organ24,25 are being identified and perivascular cytokines/chemokines appear to provide the requisite stimuli (eg, superoxide, NO, interleukin-6, tumor necrosis factor-α, vascular endothelial growth factor) for endothelial dysfunction, endothelial activation, adhesion molecule expression, and mononuclear cell retention. Finally, the specific component of PM2.5 that is responsible for “jump starting” the whole concerted activity is unidentified and remains an area of controversy. Many inhalation studies indicate that pulmonic and systemic effects of PM2.5 (or whole combustion exhaust) can be attributed to a particle fraction much smaller than 2.5 μm (eg, ultrafine or PM0.1 [<0.1 μm diameter] or nanoparticles)26,27 or even to nonparticulates/volatiles.28,–,31 Similarly, lipopolysaccharide can be a constituent of PM and can stimulate TLRs. In the present study, a VACES concentrates only ambient particles ≤2.5 μm diameter but not the ambient gases/volatiles, and, thus, the particulate fraction is clearly the trigger (noteworthy is that lipopolysaccharide levels were similar in lungs of air- and PM-exposed mice), but whether the PM2.5 or a smaller PM0.1 fraction (and what chemical constituent) is responsible remains a question.

Is the mystery solved regarding the mechanism how inhaled PM2.5 exposure stimulates vascular inflammation and injury? Well, probably not completely, but the present scenario laid out by Kampfrath et al6 connects findings from their study with many disparate human and animal epidemiological/exposure studies into a plausible story. Future studies will be required to elucidate exactly what constituent(s) of PM2.5 is (are) so prooxidant/toxic in the lung, how POVPC (or a related product) targets important cells, what specific signals regulated bone marrow–derived mononuclear cell trafficking to perivascular adipose, and whether these steps are ultimately activated in humans exposed chronically to PM2.5. One thing is clear: particulate matter matters!

Sources of Funding

The laboratory of D.J.C. is supported in part by grants from National Institute of Environmental Health Sciences; National Heart, Lung, and Blood Institute; and the Health Effects Institute.

Disclosures

None.

Footnotes

  • The opinions expressed in this editorial are not necessarily those of the editors or of the American Heart Association.

  • Non-standard Abbreviations and Acronyms

    CAP
    concentrated ambient particulate
    CVD
    cardiovascular disease
    HNE
    4-hydroxy-nonenal
    oxPAPC
    1-palmitoyl-2-arachidonyl-sn-glycero-3-phosphorylcholine
    PM
    particulate matter
    PM2.5
    particulate matter of 2.5 μm aerodynamic diameter or less
    POVPC
    1-palmitoyl-2-(5′-oxo-valeroyl)-sn-glycero-3-phosphocholine
    TLR
    Toll-like receptor
    VACES
    versatile aerosol concentration enrichment system

  • © 2011 American Heart Association, Inc.

References

  1. 1.↵
    1. Dockery DW,
    2. Pope CA III.,
    3. Xu X,
    4. Spengler JD,
    5. Ware JH,
    6. Fay ME,
    7. Ferris BG Jr.,
    8. Speizer FE
    . An association between air pollution and mortality in six U.S. cities. N Engl J Med. 1993;329:1753–1759.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Pope CA III.,
    2. Burnett RT,
    3. Thurston GD,
    4. Thun MJ,
    5. Calle EE,
    6. Krewski D,
    7. Godleski JJ
    . Cardiovascular mortality and long-term exposure to particulate air pollution: epidemiological evidence of general pathophysiological pathways of disease. Circulation. 2004;109:71–77.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    1. Pope CA III.,
    2. Muhlestein JB,
    3. May HT,
    4. Renlund DG,
    5. Anderson JL,
    6. Horne BD
    . Ischemic heart disease events triggered by short-term exposure to fine particulate air pollution. Circulation. 2006;114:2443–2448.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    1. Brook RD,
    2. Rajagopalan S,
    3. Pope CA III.,
    4. Brook JR,
    5. Bhatnagar A,
    6. Diez-Roux AV,
    7. Holguin F,
    8. Hong Y,
    9. Luepker RV,
    10. Mittleman MA,
    11. Peters A,
    12. Siscovick D,
    13. Smith SC Jr.,
    14. Whitsel L,
    15. Kaufman JD
    . Particulate matter air pollution and cardiovascular disease: an update to the scientific statement from the American Heart Association. Circulation. 2010;121:2331–2378.
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    1. Bhatnagar A
    . Environmental cardiology: studying mechanistic links between pollution and heart disease. Circ Res. 2006;99:692–705.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    1. Kampfrath T,
    2. Maiseyeu A,
    3. Ying Z,
    4. Shah Z,
    5. Deiuliis JA,
    6. Xu X,
    7. Kherada N,
    8. Brook RD,
    9. Reddy KM,
    10. Padture NP,
    11. Parthasarathy S,
    12. Chen LC,
    13. Moffatt-Bruce S,
    14. Sun Q,
    15. Morawietz H,
    16. Rajagopalan S
    . Chronic fine particulate matter exposure induces systemic vascular dysfunction via NADPH oxidase and TLR4 pathways. Circ Res. 2011;108:716–726.
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    1. Walton KA,
    2. Cole AL,
    3. Yeh M,
    4. Subbanagounder G,
    5. Krutzik SR,
    6. Modlin RL,
    7. Lucas RM,
    8. Nakai J,
    9. Smart EJ,
    10. Vora DK,
    11. Berliner JA
    . Specific phospholipid oxidation products inhibit ligand activation of toll-like receptors 4 and 2. Arterioscler Thromb Vasc Biol. 2003;23:1197–1203.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    1. Walton KA,
    2. Hsieh X,
    3. Gharavi N,
    4. Wang S,
    5. Wang G,
    6. Yeh M,
    7. Cole AL,
    8. Berliner JA
    . Receptors involved in the oxidized 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine-mediated synthesis of interleukin-8. A role for toll-like receptor 4 and a glycosylphosphatidylinositol-anchored protein. J Biol Chem. 2003;278:29661–29666.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Ketonen J,
    2. Pilvi T,
    3. Mervaala E
    . Caloric restriction reverses high-fat diet-induced endothelial dysfunction and vascular superoxide production in C57Bl/6 mice. Heart Vessels. 2010;25:254–262.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Ketonen J,
    2. Shi J,
    3. Martonen E,
    4. Mervaala E
    . Periadventitial adipose tissue promotes endothelial dysfunction via oxidative stress in diet-induced obese C57Bl/6 mice. Circ J. 2010;74:1479–1487.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Marchesi C,
    2. Ebrahimian T,
    3. Angulo O,
    4. Paradis P,
    5. Schiffrin EL
    . Endothelial nitric oxide synthase uncoupling and perivascular adipose oxidative stress and inflammation contribute to vascular dysfunction in a rodent model of metabolic syndrome. Hypertension. 2009;54:1384–1392.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. Guzik TJ,
    2. Hoch NE,
    3. Brown KA,
    4. McCann LA,
    5. Rahman A,
    6. Dikalov S,
    7. Goronzy J,
    8. Weyand C,
    9. Harrison DG
    . Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med. 2007;204:2449–2460.
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    1. Kan H,
    2. London SJ,
    3. Chen G,
    4. Zhang Y,
    5. Song G,
    6. Zhao N,
    7. Jiang L,
    8. Chen B
    . Differentiating the effects of fine and coarse particles on daily mortality in Shanghai, China. Environ Int. 2007;33:376–384.
    OpenUrlCrossRefPubMed
  14. 14.↵
    1. Chen J,
    2. Tan M,
    3. Li Y,
    4. Zheng J,
    5. Zhang Y,
    6. Shan Z,
    7. Zhang G
    . Characteristics of trace elements and lead isotope ratios in PM(2.5) from four sites in shanghai. J Hazard Mater. 2008;156:36–43.
    OpenUrlCrossRefPubMed
  15. 15.↵
    1. Kumar R,
    2. Joseph AE
    . Air pollution concentrations of PM2.5, PM10 and NO2 at ambient and Kerbsite and their correlation in metro city–Mumbai. Environ Monit Assess. 2006;119:191–199.
    OpenUrlCrossRefPubMed
  16. 16.↵
    1. Pastuszka JS,
    2. Rogula-Kozlowska W,
    3. Zajusz-Zubek E
    . Characterization of PM10 and PM2.5 and associated heavy metals at the crossroads and urban background site in Zabrze, Upper Silesia, Poland, during the smog episodes. Environ Monit Assess. 2010;168:613–627.
    OpenUrlCrossRefPubMed
  17. 17.↵
    1. O'Toole TE,
    2. Hellmann J,
    3. Wheat L,
    4. Haberzettl P,
    5. Lee J,
    6. Conklin DJ,
    7. Bhatnagar A,
    8. Pope CA III.
    . Episodic exposure to fine particulate air pollution decreases circulating levels of endothelial progenitor cells. Circ Res. 2010;107:200–203.
    OpenUrlAbstract/FREE Full Text
  18. 18.↵
    1. Rückerl R,
    2. Ibald-Mulli A,
    3. Koenig W,
    4. Schneider A,
    5. Woelke G,
    6. Cyrys J,
    7. Heinrich J,
    8. Marder V,
    9. Frampton M,
    10. Wichmann HE,
    11. Peters A
    . Air pollution and markers of inflammation and coagulation in patients with coronary heart disease. Am J Respir Crit Care Med. 2006;173:432–441.
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Ruef J,
    2. Rao GN,
    3. Li F,
    4. Bode C,
    5. Patterson C,
    6. Bhatnagar A,
    7. Runge MS
    . Induction of rat aortic smooth muscle cell growth by the lipid peroxidation product 4-hydroxy-2-nonenal. Circulation. 1998;97:1071–1078.
    OpenUrlAbstract/FREE Full Text
  20. 20.↵
    1. Minekura H,
    2. Kumagai T,
    3. Kawamoto Y,
    4. Nara F,
    5. Uchida K
    . 4-hydroxy-2-nonenal is a powerful endogenous inhibitor of endothelial response. Biochem Biophys Res Commun. 2001;282:557–561.
    OpenUrlCrossRefPubMed
  21. 21.↵
    1. Whitsett J,
    2. Picklo MJ Sr.,
    3. Vasquez-Vivar J
    . 4-hydroxy-2-nonenal increases superoxide anion radical in endothelial cells via stimulated GTP cyclohydrolase proteasomal degradation. Arterioscler Thromb Vasc Biol. 2007;27:2340–2347.
    OpenUrlAbstract/FREE Full Text
  22. 22.↵
    1. Usatyuk PV,
    2. Parinandi NL,
    3. Natarajan V
    . Redox regulation of 4-hydroxy-2-nonenal-mediated endothelial barrier dysfunction by focal adhesion, adherens, and tight junction proteins. J Biol Chem. 2006;281:35554–35566.
    OpenUrlAbstract/FREE Full Text
  23. 23.↵
    1. Lohn M,
    2. Dubrovska G,
    3. Lauterbach B,
    4. Luft FC,
    5. Gollasch M,
    6. Sharma AM
    . Periadventitial fat releases a vascular relaxing factor. FASEB J. 2002;16:1057–1063.
    OpenUrlAbstract/FREE Full Text
  24. 24.↵
    1. Gil-Ortega I,
    2. Marzoa Rivas R,
    3. Rios Vazquez R,
    4. Kaski JC
    . Role of inflammation and endothelial dysfunction in the pathogenesis of cardiac syndrome x. Future Cardiol. 2006;2:63–73.
    OpenUrlCrossRefPubMed
  25. 25.↵
    1. Gil-Ortega M,
    2. Stucchi P,
    3. Guzman-Ruiz R,
    4. Cano V,
    5. Arribas S,
    6. Gonzalez MC,
    7. Ruiz-Gayo M,
    8. Fernandez-Alfonso MS,
    9. Somoza B
    . Adaptative nitric oxide overproduction in perivascular adipose tissue during early diet-induced obesity. Endocrinology. 2010;151:3299–3306.
    OpenUrlCrossRefPubMed
  26. 26.↵
    1. Araujo JA,
    2. Barajas B,
    3. Kleinman M,
    4. Wang X,
    5. Bennett BJ,
    6. Gong KW,
    7. Navab M,
    8. Harkema J,
    9. Sioutas C,
    10. Lusis AJ,
    11. Nel AE
    . Ambient particulate pollutants in the ultrafine range promote early atherosclerosis and systemic oxidative stress. Circ Res. 2008;102:589–596.
    OpenUrlAbstract/FREE Full Text
  27. 27.↵
    1. Nurkiewicz TR,
    2. Porter DW,
    3. Hubbs AF,
    4. Stone S,
    5. Chen BT,
    6. Frazer DG,
    7. Boegehold MA,
    8. Castranova V
    . Pulmonary nanoparticle exposure disrupts systemic microvascular nitric oxide signaling. Toxicol Sci. 2009;110:191–203.
    OpenUrlAbstract/FREE Full Text
  28. 28.↵
    1. Riediker M,
    2. Williams R,
    3. Devlin R,
    4. Griggs T,
    5. Bromberg P
    . Exposure to particulate matter, volatile organic compounds, and other air pollutants inside patrol cars. Environ Sci Technol. 2003;37:2084–2093.
    OpenUrlPubMed
  29. 29.↵
    1. Campen MJ,
    2. Babu NS,
    3. Helms GA,
    4. Pett S,
    5. Wernly J,
    6. Mehran R,
    7. McDonald JD
    . Nonparticulate components of diesel exhaust promote constriction in coronary arteries from apoE-/- mice. Toxicol Sci. 2005;88:95–102.
    OpenUrlAbstract/FREE Full Text
  30. 30.↵
    1. Campen MJ,
    2. Lund AK,
    3. Doyle-Eisele ML,
    4. McDonald JD,
    5. Knuckles TL,
    6. Rohr AC,
    7. Knipping EM,
    8. Mauderly JL
    . A comparison of vascular effects from complex and individual air pollutants indicates a role for monoxide gases and volatile hydrocarbons. Environ Health Perspect. 2010;118:921–927.
    OpenUrlCrossRefPubMed
  31. 31.↵
    1. Campen MJ,
    2. Lund AK,
    3. Knuckles TL,
    4. Conklin DJ,
    5. Bishop B,
    6. Young D,
    7. Seilkop S,
    8. Seagrave J,
    9. Reed MD,
    10. McDonald JD
    . Inhaled diesel emissions alter atherosclerotic plaque composition in apoE(-/-) mice. Toxicol Appl Pharmacol. 2010;242:310–317.
    OpenUrlCrossRefPubMed
View Abstract
Back to top
Previous ArticleNext Article

This Issue

Circulation Research
March 18, 2011, Volume 108, Issue 6
  • Table of Contents
Previous ArticleNext Article

Jump to

  • Article
    • Sources of Funding
    • Disclosures
    • Footnotes
    • References
  • Figures & Tables
  • Info & Metrics

Article Tools

  • Print
  • Citation Tools
    Beware the Air!
    Daniel J. Conklin
    Circulation Research. 2011;108:644-647, originally published March 17, 2011
    https://doi.org/10.1161/CIRCRESAHA.111.241174

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
  •  Download Powerpoint
  • Article Alerts
    Log in to Email Alerts with your email address.
  • Save to my folders

Share this Article

  • Email

    Thank you for your interest in spreading the word on Circulation Research.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Beware the Air!
    (Your Name) has sent you a message from Circulation Research
    (Your Name) thought you would like to see the Circulation Research web site.
  • Share on Social Media
    Beware the Air!
    Daniel J. Conklin
    Circulation Research. 2011;108:644-647, originally published March 17, 2011
    https://doi.org/10.1161/CIRCRESAHA.111.241174
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Related Articles

Cited By...

Subjects

  • Basic, Translational, and Clinical Research
    • Mechanisms
    • Vascular Biology
    • Endothelium/Vascular Type/Nitric Oxide

Circulation Research

  • About Circulation Research
  • Editorial Board
  • Instructions for Authors
  • Abstract Supplements
  • AHA Statements and Guidelines
  • Permissions
  • Reprints
  • Email Alerts
  • Open Access Information
  • AHA Journals RSS
  • AHA Newsroom

Editorial Office Address:
3355 Keswick Rd
Main Bldg 103
Baltimore, MD 21211
CircRes@circresearch.org

Information for:
  • Advertisers
  • Subscribers
  • Subscriber Help
  • Institutions / Librarians
  • Institutional Subscriptions FAQ
  • International Users
American Heart Association Learn and Live
National Center
7272 Greenville Ave.
Dallas, TX 75231

Customer Service

  • 1-800-AHA-USA-1
  • 1-800-242-8721
  • Local Info
  • Contact Us

About Us

Our mission is to build healthier lives, free of cardiovascular diseases and stroke. That single purpose drives all we do. The need for our work is beyond question. Find Out More about the American Heart Association

  • Careers
  • SHOP
  • Latest Heart and Stroke News
  • AHA/ASA Media Newsroom

Our Sites

  • American Heart Association
  • American Stroke Association
  • For Professionals
  • More Sites

Take Action

  • Advocate
  • Donate
  • Planned Giving
  • Volunteer

Online Communities

  • AFib Support
  • Garden Community
  • Patient Support Network
  • Professional Online Network

Follow Us:

  • Follow Circulation on Twitter
  • Visit Circulation on Facebook
  • Follow Circulation on Google Plus
  • Follow Circulation on Instagram
  • Follow Circulation on Pinterest
  • Follow Circulation on YouTube
  • Rss Feeds
  • Privacy Policy
  • Copyright
  • Ethics Policy
  • Conflict of Interest Policy
  • Linking Policy
  • Diversity
  • Careers

©2018 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. The American Heart Association is a qualified 501(c)(3) tax-exempt organization.
*Red Dress™ DHHS, Go Red™ AHA; National Wear Red Day ® is a registered trademark.

  • PUTTING PATIENTS FIRST National Health Council Standards of Excellence Certification Program
  • BBB Accredited Charity
  • Comodo Secured